Larry Todd Edwards, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 2,052 shares at $25.50 ($52K) on 2026-02-02, disclosed to the SEC on 2026-02-04.
Open-market sale of $52k ARQT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARQT | SELL | 2025-10-06 | $174K | — | Filing → |
| ARQT | SELL | 2025-05-20 | $210K | — | Filing → |
| ARQT | SELL | 2025-02-04 | $28K | — | Filing → |